Taipei, Saturday, January 31, 2015 22:53 (GMT+8)
mostly cloudy
Taipei
13°C
Apex sees increase in revenues, but drop in profits in 2013 - related company info
Patty Wang, Taipei; Joseph Tsai, DIGITIMES [Thursday 26 June 2014]
  • Apex Biotechnology
  • Performance
    The company's stock price closed at NT$53.2 on the TSE on Thursday, January 29, 2015.
    The company has reported consolidated revenues of NT$171 million for December 2014, representing a 7% increase on month and 36.1% increase on year.
    For the third quarter of 2014, the company totaled NT$428 million in consolidated revenues, down 3.2% sequentially and down 5.8% on year.
    Brief

    Full name: Apex Biotechnology

    Chinese name: 五鼎生物技術股份有限公司

    Short name: Apex

    Stock code: 1733

    Tax ID: 16130182

    Market: TSE

    Established: 2 Dec 1997

    Paid in capital: NT$985.31 million

    Listed on TSE: 17 Sep 2001

    Website: www.apexbio.com

  • Latest stock
    Apex [1733] historical stock price (NT$)
    DateVolume (k)TransactionsValueOpenHighLowCloseChangeAskBid
    30-Jan 69 66 3,657,349 53.30 53.30 53.10 53.10-0.10-0.19% 53.20 53.10
    29-Jan 54   53.50 53.50 53.10 53.20-0.30-0.56%  
    28-Jan 82 62 4,379,900 53.50 53.50 53.20 53.50+0.00+0.00% 53.50 53.40
    27-Jan 126 82 6,726,957 53.40 53.70 53.30 53.50+0.20+0.38% 53.50 53.40
    26-Jan 93 80 4,939,814 53.80 53.80 53.00 53.30-0.50-0.93% 53.50 53.30
    23-Jan 132 105 7,127,246 54.00 54.50 53.60 53.80-0.20-0.37% 54.00 53.80
    22-Jan 134 106 7,253,648 53.60 54.60 53.60 54.00+0.30+0.56% 54.10 53.90
    • Source: TSE, compiled by Digitimes
    Latest sales

    Apex: Consolidated revenues, Dec 2013 - Dec 2014 (NT$m)

    Month

    Sales

    M/M

    Y/Y

    YTD

    Y/Y

    Dec-14

    171

    7%

    36.1%

    1,789

    (2.2%)

    Nov-14

    160

    (2.9%)

    39.7%

    1,618

    (5%)

    Oct-14

    165

    18.7%

    43.9%

    1,458

    (8.3%)

    Sep-14

    139

    9.9%

    (10.2%)

    1,294

    (12.3%)

    Aug-14

    126

    (22.7%)

    (18.1%)

    1,155

    (12.5%)

    Jul-14

    163

    5.8%

    11.9%

    1,029

    (11.8%)

    Jun-14

    154

    (3.9%)

    8.9%

    865

    (15.2%)

    May-14

    161

    25.9%

    (7%)

    711

    (19.1%)

    Apr-14

    127

    (7.8%)

    (30.1%)

    551

    (22%)

    Mar-14

    138

    9.7%

    (25.6%)

    423

    (19.2%)

    Feb-14

    126

    (20.7%)

    (20.4%)

    285

    (15.7%)

    Jan-14

    159

    26.5%

    (11.6%)

    159

    (11.6%)

    Dec-13

    126

    9.8%

    (20.5%)

    1,829

    (9.7%)

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, January 2015

    Apex: Consolidated revenues, 3Q13 - 3Q14 (NT$m)

    Quarter

    Sales

    Q/Q

    Y/Y

    YTD

    Y/Y

    3Q-14

    428

    (3.2%)

    (5.8%)

    1,294

    (12.3%)

    2Q-14

    442

    4.5%

    (10.9%)

    865

    (15.2%)

    1Q-14

    423

    19.4%

    (19.2%)

    423

    (19.2%)

    4Q-13

    354

    (22%)

    (26.5%)

    1,829

    (9.7%)

    3Q-13

    454

    (8.5%)

    (0.4%)

    1,475

    (4.5%)

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, January 2015

    Latest balance sheet and income statement

    Apex: Consolidated balance sheet, 3Q13 - 3Q14 (NT$k)

    Item

    3Q-2014

    2Q-2014

    1Q-2014

    4Q-2013

    3Q-2013

    Current assets

    1,443,777

    1,716,112

    1,484,403

    1,447,851

    1,347,766

    Intangible assets

    30,974

    26,283

    25,088

    26,174

    17,236

    Non-current assets

    1,239,343

    1,254,992

    1,267,321

    1,276,137

    1,341,620

    Assets

    2,683,120

    2,971,104

    2,751,724

    2,723,988

    2,689,386

    Current liabilities

    873,784

    829,041

    347,770

    383,354

    382,837

    Non-current liabilities

    27,365

    421,448

    420,792

    420,118

    421,334

    Liabilities

    901,149

    1,250,489

    768,562

    803,472

    804,171

    Stockholders' equity

    1,781,971

    1,720,615

    1,983,162

    1,920,516

    1,885,215

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, January 2015

    Apex: Consolidated income statement, 3Q13 - 3Q14 (NT$k)

    Item

    3Q-2014

    2Q-2014

    1Q-2014

    4Q-2013

    3Q-2013

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    Operating revenue

    428,083

     

    442,277

     

    423,222

     

    354,410

     

    454,277

     

    Gross profit (loss) from operations

    126,088

    29.5%

    138,765

    31.4%

    113,997

    26.9%

    106,527

    30.1%

    120,929

    26.6%

    Operating expenses

    57,677

    13.5%

    53,267

    12%

    54,100

    12.8%

    59,426

    16.8%

    51,361

    11.3%

    Operating income (loss)

    68,411

    16%

    85,498

    19.3%

    59,897

    14.2%

    48,747

    13.8%

    67,922

    15%

    Non-operating expenses and losses

    6,053

    1.4%

    -11,980

    -2.7%

    12,345

    2.9%

    -3,812

    -1.1%

    -8,211

    -1.8%

    Income from continuing operations before income tax

    74,464

    17.4%

    73,518

    16.6%

    72,242

    17.1%

    44,935

    12.7%

    59,711

    13.1%

    Net income (loss)

    60,904

    14.2%

    62,496

    14.1%

    62,129

    14.7%

    30,322

    8.6%

    51,591

    11.4%

    Diluted earnings per share (NT$)

    0.6

     

    0.6

     

    0.6

     

    0.3

     

    0.5

     

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, January 2015

  • Apex Biotechnology full profile

30-Jan-2015 markets closed

 LastChange

TAIEX (TSE)9361.91-64.99-0.69% 

TSE electronic375.12-3.70-0.98% 

GTSM (OTC)139.36+0.11+0.08% 

OTC electronic181.15+0.56+0.31% 

VOICE 2015 Developer Conference
Trends and forecasts for the China FPD industry, 2014-2017
Greater China touch panel shipment forecast through 2015
  • Wireless broadband developments in Southeast Asia markets

    As of 2013, the 10 ASEAN nations had a total of over 700 million mobile subscriptions, with the CAGR from 2003-2013 reaching 24%. This Digitimes Research Special Report analyzes the various mobile broadband markets in ASEAN and looks at the respective trends in 4G LTE development for those markets.

  • Greater China touch panel shipment forecast through 2015

    This Special Report provides forecasts through 2015 for Greater China touch panel shipments with breakdowns based on technology (glass, film, resistive), application (smartphone, NB and tablet) and by firm.

  • 2014 global tablet demand forecast

    This report analyzes the main players, their strategies and shipments forecasts for 2014, as well as other factors contributing to either growth or decline in various segments within the tablet market, with a particular focus on Apple, Google, Samsung, and Microsoft, along with whitebox vendors.